These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 26513647)
1. Pharmacotherapy of head and neck cancer. Nwizu T; Adelstein D Expert Opin Pharmacother; 2015; 16(16):2409-22. PubMed ID: 26513647 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of head and neck squamous cell carcinoma. Pan Q; Gorin MA; Teknos TN Expert Opin Pharmacother; 2009 Oct; 10(14):2291-302. PubMed ID: 19663637 [TBL] [Abstract][Full Text] [Related]
3. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study. Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925 [TBL] [Abstract][Full Text] [Related]
5. Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options? Bourhis J; Lefebvre JL; Vermorken JB Eur J Cancer; 2010 Jul; 46(11):1979-89. PubMed ID: 20561781 [TBL] [Abstract][Full Text] [Related]
6. Current concepts for the management of head and neck cancer: chemotherapy. Specenier PM; Vermorken JB Oral Oncol; 2009; 45(4-5):409-15. PubMed ID: 18715812 [TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future? Paccagnella A; Mastromauro C; D'Amanzo P; Ghi MG Oncologist; 2010; 15 Suppl 3():8-12. PubMed ID: 21036883 [TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy for head and neck cancer: will history repeat itself? Argiris A J Natl Compr Canc Netw; 2005 May; 3(3):393-403. PubMed ID: 16002005 [TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy for head and neck cancer: recent data. Vokes EE Oncologist; 2010; 15 Suppl 3():3-7. PubMed ID: 21036882 [TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834 [TBL] [Abstract][Full Text] [Related]
11. Docetaxel in the management of patients with head and neck squamous cell carcinoma. Bernier J; Vrieling C Expert Rev Anticancer Ther; 2008 Jul; 8(7):1023-32. PubMed ID: 18588449 [TBL] [Abstract][Full Text] [Related]
12. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma. Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506 [TBL] [Abstract][Full Text] [Related]
13. [Preoperative chemotherapy for patients with advanced head and neck cancer]. Tsukuda M Gan To Kagaku Ryoho; 2001 Nov; 28(12):1806-13. PubMed ID: 11729472 [TBL] [Abstract][Full Text] [Related]
14. Treatment Tolerance of Cetuximab versus Alternative Chemotherapy Agents in Non-Cisplatin Candidates with Head and Neck Cancer Receiving Concurrent Chemoradiotherapy. Morse RT; Ganju RG; Neeranjun R; Gan GN; Cao Y; Neupane P; Kakarala K; Shnayder Y; Lominska CE Chemotherapy; 2023; 68(1):35-43. PubMed ID: 35882207 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy in head and neck cancer. Merlano M; Benasso M; Cavallari M; Blengio F; Rosso M Eur J Cancer B Oral Oncol; 1994 Sep; 30B(5):283-9. PubMed ID: 7535608 [TBL] [Abstract][Full Text] [Related]
16. Cetuximab combined with radiotherapy: an alternative to chemoradiotherapy for patients with locally advanced squamous cell carcinomas of the head and neck? Bernier J; Schneider D Eur J Cancer; 2007 Jan; 43(1):35-45. PubMed ID: 17098420 [TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin. Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341 [TBL] [Abstract][Full Text] [Related]
18. [Role of Chemotherapy in head and neck cancer]. Kohno N; Kitahara S Gan To Kagaku Ryoho; 2001 Apr; 28(4):448-53. PubMed ID: 11329777 [TBL] [Abstract][Full Text] [Related]
19. Adjuvant treatment of locally-advanced head and neck tumours. Reyes López V; Navalpotro Yagüe B Clin Transl Oncol; 2005 Jun; 7(5):183-8. PubMed ID: 15960929 [TBL] [Abstract][Full Text] [Related]
20. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck. Roman E; Raez LE; Santos ES Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]